| abstract |
To discover novel factors that affect the expression level of proinflammatory factors and to provide antiproinflammatory factor expression inhibitors and development tools based thereon, as well as diagnostic agents for immune diseases, inflammatory diseases, pain diseases, etc. And providing a diagnostic method. An inflammation promoting factor expression inhibitor containing at least one selected from the group consisting of an RBMS2 expression inhibitor and an RBMS2 function inhibitor, a screening method using RBMS2 expression or function as an indicator, and an expression cassette useful for the method, And a diagnostic agent containing an RBMS2 gene expression product detection agent, and a disease detection method using the amount of RBMS2 gene expression as an index. |